CHICAGO, March 14, 2025 /PRNewswire/ — Nimblemind.ai, an AI-powered data infrastructure platform designed to help healthcare providers structure and leverage their clinical data, has secured $2.5 million in funding to accelerate its mission. The round was led by Bread & Butter Ventures, and included participation from Great Oaks Venture Capital, SpringTime Ventures, Stone Mountain Ventures, Victorum Capital, Techstars, and strategic HC angel investors committed to transforming healthcare through AI-driven data infrastructure.
The funding will enable Nimblemind.ai to accelerate its mission of making unstructured healthcare data AI-ready. By curating and labeling clinical datasets, the company is addressing one of the biggest challenges in healthcare AI—access to high-quality, structured multi-modal datasets.
“We are at an inflection point where AI can revolutionize healthcare, but without well-structured, specialty-specific data, its full potential remains untapped,” said Pi Zonooz, CEO & Co-Founder of Nimblemind.ai. “Our platform ensures that healthcare providers can unlock the value of their data for AI while maintaining sovereignty and compliance. We put the healthcare provider in the driver seat of their AI future.”
Nimblemind.ai has secured partnerships with multiple healthcare organizations in the US and Asia. The company’s proprietary approach enables clinicians to transform raw patient data into structured, AI-ready formats, paving the way for better decision-making, predictive analytics, and non-clinical revenue opportunities. “Nimblemind.ai is unlocking the power of AI in healthcare. By organizing and curating data from our EMR, patient surveys, and wearable devices, they are helping us identify patient interventions more effectively. This kind of AI-driven insight is the future of personalized, proactive care,” said Lynn M Madden, PhD, CEO of APT Foundation.
“We believe that transforming healthcare represents perhaps the single most significant application of artificial intelligence in our time, and Nimblemind.ai is building the essential foundation to realize this potential,” said Mary Grove, Managing Director of Bread & Butter Ventures. “Their platform empowers healthcare providers with everything from sophisticated clinical decision support to streamlined operations and personalized patient care. With their exceptional vision and technical expertise, the Nimblemind team is uniquely positioned to lead this revolution.”
With this funding, Nimblemind.ai plans to expand its specialty-specific AI models, enhance its platform’s capabilities, and onboard more healthcare providers seeking to leverage AI for better patient outcomes.
For more information about Nimblemind.ai, visit www.nimblemind.ai
SOURCE Nimblemind.ai
Appointment adds significant clinical and scientific expertise in the field of psychedelic-based therapiesNew York, New…
Aeroflow Urology's 97% customer satisfaction rating is a testament to the company’s commitment to personalized…
EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)…
Two IRO Platforms Ori Biotech’s IRO Platform The IRO Platform in Use A scientist uses…
-- Company taps first EU distributors, Comercial Medico Quirurigca, SA and Durgalab, as the first…
SAN MATEO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today…